GlobeNewswire

Scandinavian Tobacco Group A/S: Transaktioner i forbindelse med aktietilbagekøbsprogram

Del
Selskabsmeddelelse
Nr. 15/2021

København, 29. marts 2021

Transaktioner i forbindelse med aktietilbagekøbsprogram

Den 10. marts 2021 informerede Scandinavian Tobacco Group A/S (“STG”) om iværksættelsen af et aktietilbagekøbsprogram til en samlet pris på op til DKK 600 millioner med det formål at justere selskabets kapitalstruktur og opfylde forpligtelserne i forhold til koncernens aktiebaserede incitamentsprogram.

Aktietilbagekøbsprogrammet vil blive gennemført i overensstemmelse med EU-forordning nr. 596/2014 af 16. april 2014 (Markedsmisbrugsforordningen) og Kommissionens delegerede forordning (EU) 2016/1052, de såkaldte Safe Harbour-regler. Aktietilbagekøbsprogrammet slutter senest den 28. februar 2022.

Følgende transaktioner er foretaget i perioden 22. marts – 26. marts 2021:

Antal aktierGennemsnitlig
købspris, DKK
Transaktionsværdi, DKK
Total, seneste opgørelse191.57423.582.871
22. marts 202120.260121,842.468.458
23. marts 20216.160124,64767.755
24. marts 202120.000124,322.486.474
25. marts 202134.436123,494.252.419
26. marts 202140,000123.164,926,432
Total under tilbagekøbsprogrammet312,43038,484,409

En detaljeret oversigt over transaktioner i perioden 22.marts – 26.marts 2021 er vedhæftet denne meddelelse.

Efter de ovenstående transaktioner ejer STG i alt 3.546.678 egne aktier, svarende til 3,55% af den samlede aktiekapital.

For yderligere oplysninger kontakt venligst:
Investorhenvendelser: Torben Sand, Head of Investor Relations,
telefon: +45 5084 7222 eller torben.sand@st-group.com

Pressehenvendelser: Simon Mehl Augustesen, Director of Group Communications,
telefon: +1 484-379-8725 eller simon.augustesen@st-group.com

Vedhæftede filer


Information om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg pressemeddelelser fra GlobeNewswire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra GlobeNewswire

Skyharbour’s Partner Company Valor Completes Airborne Survey at Hook Lake Uranium Project, Saskatchewan20.4.2021 14:00:00 CEST | Press release

VANCOUVER, British Columbia, April 20, 2021 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQB: SYHBF) (Frankfurt: SC1P) (the “Company”) is pleased to announce that partner company Valor Resources Limited (“Valor”) entered into a contract with Precision GeoSurveys Inc. through TerraLogic Exploration Inc. (“TerraLogic”), the Company’s geological consultants, to undertake a detailed airborne survey over the Hook Lake Project (previously North Falcon Point). The survey commenced in early April 2021 and is now complete. TerraLogic designed the low-level airborne magnetic and VLF-EM survey to cover the entire Hook Lake claim area, using a fixed-wing aircraft, at 75m line-spacing totaling 5,100 line-km. Final data processing, data interpretation, target selection and recommendations for follow-up ground-based exploration and drilling programs will also be handled by TerraLogic. This process is expected to take approximately six weeks, followed immediately by the recommended fi

Acarix publicerar årsredovisningen för 202020.4.2021 13:00:00 CEST | Pressemelding

Pressmeddelande Malmö, 20 april 2021 Acarix publicerar årsredovisningen för 2020 Idag, tisdagen den 20 april, publicerar Acarix sin årsredovisning för verksamhetsåret 2020 på bolagets hemsida www.acarix.com. Årsredovisningen finns även bifogad i pressreleasen. För mer information, vänligen kontakta: Per Persson, vd, e-mail: per.persson@acarix.com, telefon: +46 73 600 59 90 Informationen lämnades, genom ovanstående kontaktpersons försorg, för offentliggörande vid den tidpunkt som anges av företagets nyhetsdistributör, GlobeNewswire. Om Acarix Acarix grundades 2009 och är noterat på Nasdaq First North Premier Growth Market (ticker: ACARIX). Acarix CADScor®System använder en avancerad sensor som placeras på huden ovanför hjärtat för att lyssna på ljudet av hjärtkontraktion och turbulent flöde. Det har utformats för att vara ett allt-i-ett-system i den meningen att signalen från hjärtat spelas in, bearbetas och visas som en patientspecifik s k CAD-score på skärmen. Presentation av mätresul

Acarix publishes the annual report for 202020.4.2021 13:00:00 CEST | Press release

Press release Malmö, Sweden, April 20, 2021 Acarix publishes the annual report for 2020 Today, Tuesday April 20, Acarix is publishing its Annual Report for 2020 on the company website www.acarix.com. The Annual Report is also attached to this press release. For further information, please contact: Per Persson, CEO, E-mail: per.persson@acarix.com, Phone: +46 73 600 59 90 The information was provided, through the agency of the above contact person, for publication at the time specified by the company's news distributor, GlobeNewswire. About Acarix: Acarix was established in 2009 and is listed on Nasdaq First North Premier Growth Market (ticker: ACARIX). Acarix’s CADScor®System uses an advanced sensor placed on the skin above the heart to listen to the sounds of cardiac contraction movement and turbulent flow. It has been designed to be an all-in-one system in the sense that the heart signal will be recorded, processed, and displayed as a patient specific score, the CAD-score, on the devi

GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex20.4.2021 12:30:00 CEST | Press release

– Tuberous sclerosis complex (TSC) represents a third indication for GW’s cannabidiol in Europe – – TSC causes epilepsy in up to 85% of patients, and up to 60% of those patients do not respond to standard anti-epileptic medicines1,2,3– LONDON, April 20, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the Group”), a world leader in discovering, developing and delivering regulatory approved cannabis-based medicines, today announces that the European Commission (EC) has approved the Type II variation application for EPIDYOLEX® (cannabidiol) as an adjunctive treatment of seizures associated with TSC, for patients two years of age and older. This approval, which represents the third indication for GW’s cannabidiol in Europe, paves the way for the expanded launch of the medicine across Europe. “This is an exciting moment for patients, and their families, who are affected by this debilitating disease and may benefit from this treatment. This approval is

Fingerprint Cards AB: invitation to the first quarter 2021 results presentation20.4.2021 11:30:00 CEST | Press release

Fingerprint Cards AB (Fingerprints™) will host a telephone conference and webcast presentation of its first quarter 2021 results, on April21, 2021 at 09:00 CEST. Fingerprints’ CEO Christian Fredrikson will present the report together with CFO Per Sundqvist in a combined webcast and telephone conference. The presentation will be held in English. Time: Wednesday, April 21, 2021 at 09:00 am CEST. Location: combined webcast and telephone conference. The report is available at https://www.fingerprints.com/ The webcast and the presentation material can be accessed through https://edge.media-server.com/mmc/p/5dpwm66j where it is also possible to ask questions. For media and analysts: The telephone conference dial-in is +44 (0) 2071 928000 (international participants) or 08-506 921 80 (Swedish participants). Please state conference ID 9862978. About Fingerprints Fingerprint Cards AB (Fingerprints) – the world’s leading biometrics company, with its roots in Sweden. We believe in a secure and se

Fingerprint Cards AB: inbjudan till presentation av resultatet för första kvartalet 202120.4.2021 11:30:00 CEST | Pressemelding

FingerprintCardsAB (Fingerprints™)bjuder in till telefonkonferens och en webbsänd presentation av resultatet för första kvartalet 2021, den 21april 2021 klockan 09:00. Fingerprints vd Christian Fredrikson presenterar rapporten tillsammans med CFO Per Sundqvist i en kombinerad webbsändning och telefonkonferens. Presentationen sker på engelska. Tid: onsdagen den 21 april 2021, klockan 09:00 CEST. Plats: kombinerad webbsändning och telefonkonferens. Rapporten finns på https://www.fingerprints.com/ Webbsändningen och presentationsmaterialet finns på https://edge.media-server.com/mmc/p/5dpwm66j där man även har möjlighet att ställa frågor. För media och analytiker: Telekonferensen nås via +44 (0) 2071 928000 (internationella deltagare) eller 08-506 921 80 (svenska deltagare). V.g. uppge konferens-ID 9862978. Om Fingerprints Fingerprint Cards AB (Fingerprints) - det ledande globala biometribolaget med svenska rötter. Vi tror på en säker och sammanbunden värld, där du är nyckeln till allt. Vå

RESULT OF RIKSBANK REVERSED AUCTIONS KOMMUNINVEST BONDS20.4.2021 11:10:00 CEST | Press release

RESULT OF RIKSBANK REVERSED AUCTIONS KOMMUNINVEST BONDS Auction date2021-04-20Loan2410 Coupon1.00 %ISIN-codeSE0010469205Maturity2024-10-02 Tendered volume, SEK mln500 +/- 250 Volume offered, SEK mln2,250Volume bought, SEK mln750 Number of bids8 Number of accepted bids2 Average yield0.088 %Lowest accepted yield0.087 %Highest yield0.088 %% accepted at lowest yield 50.00 Auction date2021-04-20Loan2602 Coupon0.75 %ISIN-codeSE0013745452Maturity2026-02-04 Tendered volume, SEK mln500 +/- 250 Volume offered, SEK mln2,000 Volume bought, SEK mln500 Number of bids5 Number of accepted bids1 Average yield0.288 %Lowest accepted yield0.288 %Highest yield0.288 %% accepted at lowest yield 100.00 Auction date2021-04-20LoanG2306Coupon0.625 %ISIN-codeXS1897258098Maturity2023-06-01 Tendered volume, SEK mln250 +/- 250 Volume offered, SEK mln0 Volume bought, SEK mln0 Number of bids0 Number of accepted bids0 Average yieldNALowest accepted yieldNAHighest yieldNA% accepted at lowest yield NA